GSK Logo

site-logo

Are you a Healthcare Professional? Visit the Healthcare Professional website.

Volibris

ambrisentan

Product information

Volibris summary of product characteristics     Volibris patient information leaflet

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
Volibris is a registered trademark of the GlaxoSmithKline Group of Companies

M.C: Last updated 14 April 2015: UK/COM/0021/15